These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27472513)

  • 1. INTRAVITREAL RANIBIZUMAB AS AN ADJUNCTIVE TREATMENT FOR COATS DISEASE (6-YEAR FOLLOW-UP).
    Giannakopoulos M; Drimtzias E; Panteli V; Vasilakis P; Gartaganis SP
    Retin Cases Brief Rep; 2017 Fall; 11(4):339-343. PubMed ID: 27472513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.
    Zhang L; Ke Y; Wang W; Shi X; Hei K; Li X
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1339-1346. PubMed ID: 29549425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
    Li S; Deng G; Liu J; Ma Y; Lu H
    BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease.
    Yang Q; Wei W; Shi X; Yang L
    Acta Ophthalmol; 2016 Jun; 94(4):401-6. PubMed ID: 27150442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.
    Wang KY; Cheng CK
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):525-30. PubMed ID: 21951171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
    Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
    BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INTRAVITREAL RANIBIZUMAB INJECTION AND RETINAL LASER PHOTOCOAGULATION TREATMENT FOR ADULT-ONSET COATS DISEASE.
    Plaza-Laguardia C; Pascual-Camps I; Bayón-Porras MR; Sánchez-Cañizal J; Gallego-Pinazo R
    Retin Cases Brief Rep; 2021 Sep; 15(5):532-535. PubMed ID: 31913217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWO-YEAR RESULTS OF INTRAVITREAL INJECTIONS OF AFLIBERCEPT IN COATS DISEASE: A CASE REPORT.
    Georgakopoulos CD; Tsapardoni FN; Makri OE; Vavvas D
    Retin Cases Brief Rep; 2022 Jul; 16(4):473-478. PubMed ID: 32541440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
    Lin CJ; Chen SN; Hwang JF; Yang CM
    J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ranibizumab in the management of advanced Coats disease Stages 3B and 4: long-term outcomes.
    Gaillard MC; Mataftsi A; Balmer A; Houghton S; Munier FL
    Retina; 2014 Nov; 34(11):2275-81. PubMed ID: 25075562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab.
    Ladaique M; Dirani A; Ambresin A
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):542-7. PubMed ID: 25902117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and complications of intravitreal anti-vascular endothelial growth factor agents combined with ablative therapies in juvenile Coats disease: a five year follow-up study.
    Li L; Li S; Liu J; Deng G; Ma J; Lu H
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):305-312. PubMed ID: 37421483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of stage 3B Coats disease: presentation of a combined treatment modality and long-term follow-up.
    Liang T; Peng J; Zhang Q; Zhu X; Xu Y; Zhao P
    Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):2031-2038. PubMed ID: 32474693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization.
    Do DV; Bressler SB; Cassard SD; Gower EW; Tabandeh H; Jefferys JL; Bressler NM
    Retina; 2014 Oct; 34(10):2063-71. PubMed ID: 24978428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
    Saishin Y; Ito Y; Fujikawa M; Sawada T; Ohji M
    Jpn J Ophthalmol; 2017 Jan; 61(1):67-73. PubMed ID: 27660163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
    Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
    Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coats disease with retinal neovascularization under subfoveal nodule: optical coherence tomography-angiography findings before and after ranibizumab treatment.
    Dundar SO; Verdi F; Unsal AIA
    Arq Bras Oftalmol; 2021; 84(4):383-386. PubMed ID: 34008799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
    Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
    Kim KH; Kim JH; Chang YS; Lee TG; Kim JW; Lew YJ
    Korean J Ophthalmol; 2015 Oct; 29(5):315-24. PubMed ID: 26457037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.